- Home
- LFVN vs TARA Comparison
LFVN vs TARA Comparison
Compare LFVN & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFVN
- TARA
- Stock Information
- Founded
- LFVN N/A
- TARA N/A
- Country
- LFVN United States
- TARA United States
- Employees
- LFVN N/A
- TARA N/A
- Industry
- LFVN Biotechnology: Pharmaceutical Preparations
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LFVN Health Care
- TARA Health Care
- Exchange
- LFVN Nasdaq
- TARA Nasdaq
- Market Cap
- LFVN 145.2M
- TARA 118.1M
- IPO Year
- LFVN N/A
- TARA N/A
- Fundamental
- Price
- LFVN $11.13
- TARA $3.14
- Analyst Decision
- LFVN Strong Buy
- TARA Strong Buy
- Analyst Count
- LFVN 2
- TARA 6
- Target Price
- LFVN $30.50
- TARA $19.80
- AVG Volume (30 Days)
- LFVN 161.9K
- TARA 151.2K
- Earning Date
- LFVN 10-28-2025
- TARA 11-11-2025
- Dividend Yield
- LFVN 1.62%
- TARA N/A
- EPS Growth
- LFVN 226.09
- TARA N/A
- EPS
- LFVN 0.75
- TARA N/A
- Revenue
- LFVN $228,530,000.00
- TARA N/A
- Revenue This Year
- LFVN $12.65
- TARA N/A
- Revenue Next Year
- LFVN $12.43
- TARA N/A
- P/E Ratio
- LFVN $14.84
- TARA N/A
- Revenue Growth
- LFVN 14.17
- TARA N/A
- 52 Week Low
- LFVN $9.00
- TARA $1.60
- 52 Week High
- LFVN $27.38
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- LFVN 36.56
- TARA 49.92
- Support Level
- LFVN $10.30
- TARA $3.05
- Resistance Level
- LFVN $12.10
- TARA $3.30
- Average True Range (ATR)
- LFVN 0.96
- TARA 0.14
- MACD
- LFVN -0.22
- TARA 0.00
- Stochastic Oscillator
- LFVN 20.85
- TARA 35.71
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).